Paroxetine response and tolerability among ethnic minority patients with mood or anxiety disorders: A pooled analysis

Journal of Clinical Psychiatry

Volumn 66, Issue 10, 2005, Pages 1228-1233

  Roy Byrne, Peter P ^a   Perera, Philip ^b   Pitts, Cornelius D ^b   Christi, Jacquie A ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GLAXOSMITHKLINE   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; PLACEBO;

ADULT; AGED; ANOREXIA; ANXIETY; ANXIETY DISORDER; ARTICLE; ASIAN; CAUCASIAN; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE CLASSIFICATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; EJACULATION DISORDER; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; GENERALIZED ANXIETY DISORDER; GROUP DYNAMICS; HISPANIC; HUMAN; IMPOTENCE; INSOMNIA; LIBIDO DISORDER; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEASUREMENT; MOOD DISORDER; NAUSEA; NEGRO; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; SOCIAL PHOBIA; SOMNOLENCE; SWEATING; TREATMENT INDICATION; TREATMENT OUTCOME; TREMOR; XEROSTOMIA;

EID: 27544484873     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n1004     Document Type: Article

References (20)

1. Young AS, Klap R, Sherbourne CD, et al. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001;58:55-61
2. Wang PS, Berglund P, Kessler RC. Recent care of common mental disorders in the United States: prevalence and conformance with evidence-based recommendations. J Gen Intern Med 2000;15:284-292
3. Padgett DK, Patrick C, Burns BJ, et al. Ethnicity and the use of outpatient mental health services in a national insured population. Am J Public Health 1994;84:222-226
4. Zhang AY, Snowden LR, Sue S. Differences between Asian and white Americans' help-seeking and utilization patterns in the Los Angeles area. J Community Psychol 1998;26:317-326
5. US Department of Health and Human Services. Mental Health: Culture, Race, and Ethnicity: A Supplement to Mental Health: A Report of the Surgeon General. Rockville, Md: US Dept Health Human Services, Public Health Service, Office of the Surgeon General; 2001
6. Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: Institute of Medicine, The National Academies Press; 2003
7. Lin KM, Smith MW, Ortiz V. Culture and psychopharmacology. Psychiatr Clin North Am 2001;24:523-538
8. LaVeist TA, Diala C, Jarrett NC. Social status and perceived discrimination: who experiences discrimination in the health care system, how, and why? In: Hogue C, Hargraves M, Scott-Collins K, eds. Minority Health in America. Baltimore, Md: Johns Hopkins University Press; 2000:194-208
9. Cooper-Patrick L, Gallo JJ, Gonzales JJ, et al. Race, gender, and partnership in the patient-physician relationship. JAMA 1999;282:583-589
10. Yeung A, Kung WW. How culture impacts on the treatment of mental illnesses among Asian-Americans. Psychiatric Times 2004;21:34-36
11. Marin H, Escobar JI. Special issues in the psychopharmacological management of Hispanic Americans. Psychopharmacol Bull 2001;35:197-212
12. Ballenger JC. Clinical guidelines for establishing remission in patients with depression and anxiety. J Clin Psychiatry 1999;60(suppl 22):29-34
13. Thase ME. Comparing the methods used to compare antidepressants. Psychopharmacol Bull 2002;36(suppl 1):1-17
14. Wagner GJ, Maguen S, Rabkin JG. Ethnic differences in response to fluoxetine in a controlled trial with depressed HIV-positive patients. Psychiatr Serv 1998;49:239-240
15. Escobar JI, Tuason VB. Antidepressant agents: a cross-cultural study. Psychopharmacol Bull 1980;16:49-52
16. Plewes J, Bailey R, Mallinckrodt C, et al. Duloxetine for the treatment of major depressive disorder in Hispanic and African American patients. Presented at the 157th annual meeting of the American Psychiatric Association; May 1-6, 2004; New York, NY
17. Dwight-Johnson M, Sherbourne CD, Liao D, et al. Treatment preferences among depressed primary care patients. J Gen Intern Med 2000;15:527-534
18. Hazlett-Stevens H, Craske MG, Roy-Byrne PP, et al. Predictors of willingness to consider medication and psychosocial treatment of panic disorder in a primary care sample. Gen Hosp Psychiatry 2002;24:316-321
19. Poolsup N, Li Wan Po A, Knight TL. Pharmacogenetics and psychopharmacotherapy. J Clin Pharm Ther 2000;25:197-220
20. Daly AK, Brockmoller J, Broly F, et al. Nomenclature for human CYP2D6 alleles. Pharmacogenetics 1996;6:193-201